- Home
- GOVX vs PTN Comparison
GOVX vs PTN Comparison
Compare GOVX & PTN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GOVX
- PTN
- Stock Information
- Founded
- GOVX 2001
- PTN 1986
- Country
- GOVX United States
- PTN United States
- Employees
- GOVX N/A
- PTN N/A
- Industry
- GOVX Biotechnology: Pharmaceutical Preparations
- PTN Biotechnology: Pharmaceutical Preparations
- Sector
- GOVX Health Care
- PTN Health Care
- Exchange
- GOVX Nasdaq
- PTN Nasdaq
- Market Cap
- GOVX 23.8M
- PTN 25.4M
- IPO Year
- GOVX N/A
- PTN 1993
- Fundamental
- Price
- GOVX $2.26
- PTN $0.78
- Analyst Decision
- GOVX Strong Buy
- PTN Strong Buy
- Analyst Count
- GOVX 5
- PTN 1
- Target Price
- GOVX $14.20
- PTN $17.00
- AVG Volume (30 Days)
- GOVX 715.7K
- PTN 365.1K
- Earning Date
- GOVX 11-12-2024
- PTN 02-13-2025
- Dividend Yield
- GOVX N/A
- PTN N/A
- EPS Growth
- GOVX N/A
- PTN N/A
- EPS
- GOVX N/A
- PTN N/A
- Revenue
- GOVX $3,090,161.00
- PTN $2,384,113.00
- Revenue This Year
- GOVX N/A
- PTN N/A
- Revenue Next Year
- GOVX $150.51
- PTN N/A
- P/E Ratio
- GOVX N/A
- PTN N/A
- Revenue Growth
- GOVX N/A
- PTN N/A
- 52 Week Low
- GOVX $1.09
- PTN $0.68
- 52 Week High
- GOVX $11.18
- PTN $5.65
- Technical
- Relative Strength Index (RSI)
- GOVX 44.80
- PTN 34.59
- Support Level
- GOVX $2.17
- PTN $0.82
- Resistance Level
- GOVX $2.50
- PTN $0.99
- Average True Range (ATR)
- GOVX 0.17
- PTN 0.11
- MACD
- GOVX -0.04
- PTN -0.02
- Stochastic Oscillator
- GOVX 18.33
- PTN 16.64
About GOVX GeoVax Labs Inc.
Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. GeoVax's product pipeline includes ongoing human clinical trials for a next-generation COVID-19 vaccine and a gene-directed therapy against head and neck cancers. Additional research and development programs include preventive vaccines against Monkeypox (MPox), hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan, Marburg, and Lassa), and Zika virus, as well as immunotherapies for multiple solid tumors.
About PTN Palatin Technologies Inc.
Palatin Technologies Inc is a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system. The product candidates are targeted, receptor-specific therapeutics for the treatment of diseases with significant unmet medical need and commercial potential.